PUBLISHER: Orion Market Research Pvt Ltd | PRODUCT CODE: 1159426
PUBLISHER: Orion Market Research Pvt Ltd | PRODUCT CODE: 1159426
Global Kidney and Pancreas Transplant Market Size, Share & Trends Analysis Report by Sources (Living Donors, and Deceased Donors) by Treatment ((Analgesic, Immunosuppressant, and Others) by End User (Hospitals, Transplant Centers, and Others) Forecast 2022-2028
The global kidney and pancreas transplant market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2021-2028). The prominent factor that fueled the growth of the market is the higher consumption of salts in food; they blocked the pores of the kidney which causes a severe problem during filtration. Moreover, rising consumption of alcohol, hereditary conditions, trauma, medications, infections, and high lipid levels in the body, results in pancreatic disease. According to, Global Health Now in 2018-2019, the state Government of India earned collective revenue of $19.8 billion from the sale of alcohol. Maharashtra reported sales worth $8.2 million from selling 1.6 million liters of alcohol, and Uttar Pradesh, sold liquor worth, $13.2 million. The surge in the consumption of salts, alcohol, and the increasing prevalence of pancreatic diseases, fueled the growth of the global kidney and pancreas transplant market. `
Moreover, the high cost of treatment, and the risk of minor infections such as urinary tract infections (UTIs), is restraining the growth of the market. The key market players are opting for different strategies, and ways to stay competitive in the global market. For instance, in March 2022, Fresenius Medical Care announced a binding agreement with InterWell Health and Cricket Health. The merger brings together Fresenius Health Partners' expertise in kidney care value and broadens their offer by adding significant value to patients with chronic kidney diseases all over the US.
The global kidney and pancreas transplant market is segmented on the basis of sources, treatment, and end user. Based on sources, the market is sub-divided into living donors, deceased donors. Based on treatment, the market is bifurcated into analgesic, immunosuppressant, others. Based on end user, the market is sub-segmented into hospitals, transplant centers, others. Based on treatment, the analgesic segment is anticipated to grow at the highest CAGR during the forecast period. The growth is primarily driven by an increase in the incidence of chronic diseases, such as tuberculosis (TB), cancer, and arthritis. In addition, with a substantial rise in the number of patients due to infectious diseases such as gastrointestinal, respiratory, and neurology, an analgesic is used as a pain killer, hence rises in the number of chronic diseases, is expected to further drive the analgesic market share in coming future.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The European region is anticipated to grow at the fastest rate, owing to a rise in deceased donors and a higher prevalence of kidney-related diseases in the region. For instance, according to European Union, a total of 21,227 (19.9 % from living donors), organs were transplanted in 2018 from 28 EU countries, and 745 were transplanted for the pancreas. Moreover, in 2018, the number of actual deceased donors ranged from 48.3 per million people in Spain, 40.2 per million in Croatia, and 33.4 per million in Portugal. Hence, the rise in the number of deceased donors in various European regions contributes to the growth of the market during the forecast period.
The major companies serving the global kidney and pancreas transplant market are AbbVie Inc, Medtronic plc, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Luminex, Organ Recovery Systems Inc., and Organogenesis and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaboration, funding, and new product launches, to stay competitive in the market. For instance, in March 2021, Strive Health announced that the company secured a $140million Series B round of funding led by CapitalG, Alphabet's independent growth fund. The financing supports the growing demand for strive's innovative whole-patient solutions for kidney disease populations. Moreover, strive's model with advanced technology, along with high-touch patient care slows kidney disease progression, prevents unnecessary and costly hospitalization, and expands access to optimal renal replacement therapies such as home dialysis, and transplants.
Research Methodology
The market study of the global kidney and pancreas transplant market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: